Medicine
Weight-loss drug reduces cravings for opioids in small study
A first-of-its-kind trial found that GLP-1 agonists, a popular kind of weight-loss drug, could help people overcome their opioid cravings.
The untapped potential of stem cells in menstrual blood
Stem cells found in menstrual blood could unlock new therapies and diagnostic tests, some researchers argue.
Evidence that gamma rhythm stimulation can treat neurological disorders is emerging
Researchers survey the therapeutic potential of noninvasive sensory, electrical, or magnetic stimulation of gamma brain rhythms.
New pharma supergroup aims to tackle skin disorders
Six biotech companies just merged to form Alys Pharmaceuticals with the goal of developing new treatments for skin disorders.
How to stop our immune systems from turning on us
From "inverse vaccines" to repurposed cancer therapies, several potential cures for autoimmune diseases are showing serious promise.
New hope for early pancreatic cancer intervention via AI-based risk prediction
To train their machine learning models, MIT researchers used electronic health record data from various institutions across the U.S.
One-shot CRISPR treatment for inherited disease aces first human trial
A CRISPR treatment for hereditary angioedema significantly reduced swelling attacks in its first human trial.
New non-opioid pain reliever moves closer to approval
Vertex Pharmaceuticals’ new painkiller, VX-548, significantly reduced moderate-to-severe pain in two phase 3 trials.
Inhalable sensors could enable early lung cancer detection
MIT engineers have designed diagnostic particles that can be aerosolized and inhaled to find cancer-associated proteins in the lungs.
Anti-aging pill for senior dogs is now in clinical trials
An anti-aging pill for senior dogs now in clinical trials might lead to treatments that extend human lives, too.